TEQLX
Price
$11.01
Change
-$0.26 (-2.31%)
Updated
Apr 3 closing price
Net Assets
7.29B
VEMAX
Price
$37.01
Change
-$0.71 (-1.88%)
Updated
Apr 3 closing price
Net Assets
110.13B
Ad is loading...

TEQLX vs VEMAX

Header iconTEQLX vs VEMAX Comparison
Open Charts TEQLX vs VEMAXBanner chart's image
Nuveen Emerging Markets Eq Idx R6
Price$11.01
Change-$0.26 (-2.31%)
VolumeN/A
Net Assets7.29B
Vanguard Emerging Mkts Stock Idx Adm
Price$37.01
Change-$0.71 (-1.88%)
VolumeN/A
Net Assets110.13B
TEQLX vs VEMAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
TEQLX vs. VEMAX commentary
Apr 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is TEQLX is a Hold and VEMAX is a Hold.

Ad is loading...
FUNDAMENTALS
Fundamentals
VEMAX has more cash in the bank: 110B vs. TEQLX (7.29B). VEMAX pays higher dividends than TEQLX: VEMAX (3.08) vs TEQLX (2.82). TEQLX was incepted earlier than VEMAX: TEQLX (15 years) vs VEMAX (19 years). TEQLX (0.16) is less costly to investors than VEMAX (0.13). TEQLX is a more actively managed with annual turnover of: 14.00 vs. VEMAX (8.00). VEMAX has a lower initial minimum investment than TEQLX: VEMAX (3000) vs TEQLX (1000000). VEMAX annual gain was more profitable for investors over the last year : 9.76 vs. TEQLX (8.63). VEMAX return over 5 years is better than : 51.99 vs. TEQLX (47.28).
TEQLXVEMAXTEQLX / VEMAX
Total Expense Ratio0.160.13123%
Annual Report Gross Expense Ratio0.160.13123%
Fund Existence15 years19 years-
Gain YTD4.6432.645176%
Front LoadN/AN/A-
Min. Initial Investment1000000300033,333%
Min. Initial Investment IRAN/AN/A-
Net Assets7.29B110B7%
Annual Yield % from dividends2.823.0891%
Returns for 1 year8.639.7688%
Returns for 3 years0.922.4238%
Returns for 5 years47.2851.9991%
Returns for 10 years28.9227.47105%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RYBOX53.49N/A
N/A
Rydex Biotechnology A
FVDFX37.14N/A
N/A
Fidelity Value Discovery
VBINX47.04N/A
N/A
Vanguard Balanced Index Inv
MSGAX11.25N/A
N/A
Meridian Small Cap Growth A
HFDCX17.34N/A
N/A
Hartford Schroders US MidCap Opps C